Cns Pharmaceuticals, Inc.6月10日成交额为26.52万美元

市场透视2025-06-11

美东时间2025年6月10日，Cns Pharmaceuticals, Inc.（CNSP.US）成交额为26.52万美元，成交额较昨日增加41.65%，当日成交量为26.48万股。Cns Pharmaceuticals, Inc.（CNSP.US）于2025年6月10日跌4.85%，报0.98美元，该股过去5个交易日跌2.97%，年初至今跌83.67%，过去60日跌68.59%。|近5个交易日...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2542322387?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-11 09:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2542322387","market":"us","top_or_hot":-1,"title":"Cns Pharmaceuticals, Inc.6月10日成交额为26.52万美元","media":"市场透视","content":"<div>\n<p>美东时间2025年6月10日，Cns Pharmaceuticals, Inc.（CNSP.US）成交额为26.52万美元，成交额较昨日增加41.65%，当日成交量为26.48万股。Cns Pharmaceuticals, Inc.（CNSP.US）于2025年6月10日跌4.85%，报0.98美元，该股过去5个交易日跌2.97%，年初至今跌83.67%，过去60日跌68.59%。|近5个交易日...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611093503a4a2b1c5&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cns Pharmaceuticals, Inc.6月10日成交额为26.52万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCns Pharmaceuticals, Inc.6月10日成交额为26.52万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-11 09:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611093503a4a2b1c5&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>美东时间2025年6月10日，Cns Pharmaceuticals, Inc.（CNSP.US）成交额为26.52万美元，成交额较昨日增加41.65%，当日成交量为26.48万股。Cns Pharmaceuticals, Inc.（CNSP.US）于2025年6月10日跌4.85%，报0.98美元，该股过去5个交易日跌2.97%，年初至今跌83.67%，过去60日跌68.59%。|近5个交易日...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611093503a4a2b1c5&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611093503a4a2b1c5&s=b","article_id":"2542322387","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611093503a4a2b1c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2542322387","pubTimestamp":1749605544,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"美东时间2025年6月10日，Cns Pharmaceuticals, Inc.成交额为26.52万美元，成交额较昨日增加41.65%，当日成交量为26.48万股。Cns Pharmaceuticals, Inc.于2025年6月10日跌4.85%，报0.98美元，该股过去5个交易日跌2.97%，年初至今跌83.67%，过去60日跌68.59%。该公司参与了 Berubicin 的开发，它是一种治疗胶质母细胞瘤的疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","CNSP":"CNS Pharmaceuticals, Inc."},"translate_title":"Cns Pharmaceuticals, Inc. turnover of $265,200 on June 10","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CNSP":0.9},"content_text":"美东时间2025年6月10日，Cns Pharmaceuticals, Inc.（CNSP.US）成交额为26.52万美元，成交额较昨日增加41.65%，当日成交量为26.48万股。Cns Pharmaceuticals, Inc.（CNSP.US）于2025年6月10日跌4.85%，报0.98美元，该股过去5个交易日跌2.97%，年初至今跌83.67%，过去60日跌68.59%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-10|26.52万|41.65%|26.48万|#|2025-06-09|18.72万|-11.34%|18.32万|#|2025-06-06|21.11万|20.95%|20.24万|#|2025-06-05|17.46万|0.56%|17.19万|#|2025-06-04|17.36万|-58.16%|16.69万|CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。 该公司参与了 Berubicin 的开发，它是一种治疗胶质母细胞瘤的疗法。 胶质母细胞瘤是由星形胶质细胞产生的肿瘤，而星形胶质细胞是构成大脑支持组织的星形细胞。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2542322387","isCrawlerRequest":true}